Adial Pharmaceuticals Inc (ADIL)

NASDAQ

$2.74

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapies for the treatment or prevention of addictions and related disorders. The company is headquartered in Charlottesville, Virginia.

Website: https://www.adial.com

Sector:

Healthcare

Industry:

Biotechnology

68 analysts

Strong Buy

Target: $7 (+155.47%)

Market Cap

$4.24M

Beta (5Y)

0.82

Price Chart

Adjust inflation

Log

Valuation

Market Cap$4.24M

P/B1.65

Profitability

EBITDA-$7.77M

EPS-$7.29

Growth & Risk

FCF 5Y CAGR+0.24%

Beta (5Y)0.82

Sharpe Ratio-1.11